AstraZeneca’s Global Technology Centre in Chennai rebranded as Global Innovation and Technology Centre
2 min read
CHENNAI: AstraZeneca India Private Confined (AZIPL), the World Capability Centre (GCC) of AstraZeneca, introduced on Wednesday that it has repositioned its Global Technological innovation Centre (GTC) in Chennai to emphasis on driving improved innovation, ensuing in a rebrand of the centre to World wide Innovation and Know-how Centre (GITC).
The GTC in Chennai has labored on IT companies and capabilities for AstraZeneca’s world wide small business above the past eight many years. Because inception, the centre has evolved its presenting from common IT services into a important engine for AstraZeneca’s electronic journey and ongoing resource of technological know-how innovation.
The Chennai centre has performed a crucial function in driving productivity, simplification, technologies shipping and delivery and innovation throughout AstraZeneca’s company and in assistance of daily life-shifting medicines shipped to individuals worldwide.
The rebranding marks the centre’s evolution of capabilities, dedication to driving innovation and shifting the company in the direction of a digitally-enabled upcoming.
“Our centre in Chennai continues to participate in a strategic function in our digital transformation, doing the job on visualisation, knowledge & analytics, hyperautomation, XR/VR abilities, between other areas. These systems and innovations engage in a vital part in aiding us progress our science, anticipate client desires and do the job seamlessly across our firm. I am thrilled to see that the do the job shipped by the staff in Chennai is currently being mirrored in our transition from GTC to GITC,” Cindy Hoots, main digital workplace and CIO, AstraZeneca, said, in a assertion.
“With near to 2,800 very proficient staff members, GITC is now just one of the greatest technologies centres across the everyday living sciences industry in the state. The robust collaboration we have been ready to build between field, academia and the government has aided us in our pursuit of enabling good abilities at scale across the company’s value chain. Our GITC aims at bringing the ideal of technologies, innovation and persons to the forefront to handle the ever-evolving health care and engineering landscape. The rebranding is a strong acknowledgement of the strategic significance our Chennai centre plays in our global functions,” Siva Padmanabhan, taking care of director, AstraZeneca India Private Constrained (AZIPL), mentioned.
Both AZIPL centres in Chennai and Bengaluru offer you staff members a favourable, physiologically safe, effective and collaborative function culture with ample options for personal development and enlargement, AstraZeneca reported.
The GTC in Chennai has labored on IT companies and capabilities for AstraZeneca’s world wide small business above the past eight many years. Because inception, the centre has evolved its presenting from common IT services into a important engine for AstraZeneca’s electronic journey and ongoing resource of technological know-how innovation.
The Chennai centre has performed a crucial function in driving productivity, simplification, technologies shipping and delivery and innovation throughout AstraZeneca’s company and in assistance of daily life-shifting medicines shipped to individuals worldwide.
The rebranding marks the centre’s evolution of capabilities, dedication to driving innovation and shifting the company in the direction of a digitally-enabled upcoming.
“Our centre in Chennai continues to participate in a strategic function in our digital transformation, doing the job on visualisation, knowledge & analytics, hyperautomation, XR/VR abilities, between other areas. These systems and innovations engage in a vital part in aiding us progress our science, anticipate client desires and do the job seamlessly across our firm. I am thrilled to see that the do the job shipped by the staff in Chennai is currently being mirrored in our transition from GTC to GITC,” Cindy Hoots, main digital workplace and CIO, AstraZeneca, said, in a assertion.
“With near to 2,800 very proficient staff members, GITC is now just one of the greatest technologies centres across the everyday living sciences industry in the state. The robust collaboration we have been ready to build between field, academia and the government has aided us in our pursuit of enabling good abilities at scale across the company’s value chain. Our GITC aims at bringing the ideal of technologies, innovation and persons to the forefront to handle the ever-evolving health care and engineering landscape. The rebranding is a strong acknowledgement of the strategic significance our Chennai centre plays in our global functions,” Siva Padmanabhan, taking care of director, AstraZeneca India Private Constrained (AZIPL), mentioned.
Both AZIPL centres in Chennai and Bengaluru offer you staff members a favourable, physiologically safe, effective and collaborative function culture with ample options for personal development and enlargement, AstraZeneca reported.
